Organigram Global (OGI) Interest Expenses (2018 - 2021)
Organigram Global (OGI) posted quarterly Interest Expenses of $2.8 million for Q2 2021, up 77.73% year-on-year from $1.6 million in Q2 2020, and up 18.26% on a QoQ basis from $2.4 million in Q1 2021.
Organigram Global (OGI) Interest Expenses (2018 - 2021) Analysis & Trends
Organigram Global (OGI) has reported Interest Expenses for 4 consecutive years, with $2.8 million the latest figure, recorded in Q2 2021.
- Quarterly Interest Expenses rose 77.73% year-over-year to $2.8 million in Q2 2021, while the trailing twelve-month figure through Aug 2022 was $2.8 million (down 58.47% YoY) and the FY2023 annual result came in at $223248.4, changed N/A from the prior year.
- Interest Expenses rose to $2.8 million in Q2 2021 per OGI's latest filing, from $2.4 million in the prior quarter.
- Over the last five years, Interest Expenses for OGI reached as high as $4.3 million in Q1 2019 and fell as low as $282989.2 in Q2 2019.
- A 4-year average of $2.2 million and a median of $2.0 million in 2020 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2019 — Interest Expenses tumbled 93.35% — and 2020, when it surged 461.49%.
- Year by year, Interest Expenses stood at $4.2 million in 2018, then sank by 85.84% to $593769.9 in 2019, then jumped by 167.44% to $1.6 million in 2020, then jumped by 77.83% to $2.8 million in 2021.
- According to Business Quant data, Interest Expenses over the past three periods registered $2.8 million, $2.4 million, and $1.6 million for Q2 2021, Q1 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2021 | 2.82 Mn |
| May 31, 2021 | 2.82 Mn |
| Feb 28, 2021 | 2.39 Mn |
| Feb 28, 2021 | 2.39 Mn |
| Nov 30, 2020 | 1.59 Mn |
| Nov 30, 2020 | 1.59 Mn |
| Aug 31, 2020 | 711,429.17 |
| Aug 31, 2020 | 711,429.17 |
| May 31, 2020 | 1.59 Mn |
| May 31, 2020 | 1.59 Mn |
| Feb 29, 2020 | 1.97 Mn |
| Feb 29, 2020 | 1.97 Mn |
| Aug 31, 2019 | 593,769.85 |
| Aug 31, 2019 | 593,769.85 |
| May 31, 2019 | 282,989.18 |
| May 31, 2019 | 282,989.18 |
| Feb 28, 2019 | 4.31 Mn |
| Feb 28, 2019 | 4.31 Mn |
| Nov 30, 2018 | 4.19 Mn |
| Nov 30, 2018 | 4.19 Mn |